134 related articles for article (PubMed ID: 35749760)
41. Focal nodular hyperplasia and hepatocellular adenoma: current views.
Dimitroulis D; Charalampoudis P; Lainas P; Papanikolaou IG; Kykalos S; Kouraklis G
Acta Chir Belg; 2013; 113(3):162-9. PubMed ID: 24941710
[TBL] [Abstract][Full Text] [Related]
42. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
43. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
[TBL] [Abstract][Full Text] [Related]
44. Large Regenerative Nodules and Focal Nodular Hyperplasia-Like Lesions: Definition, Pathogenesis, and Imaging Findings.
Nolan PE; Catania R; Vendrami CL; Borhani AA; Miller FH
Radiol Clin North Am; 2022 Sep; 60(5):795-808. PubMed ID: 35989045
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.
Shafizadeh N; Kakar S
Adv Anat Pathol; 2011 Nov; 18(6):438-45. PubMed ID: 21993269
[TBL] [Abstract][Full Text] [Related]
46. [Focal nodular hyperplasia that was difficult to differentiate from hepatocellular carcinoma].
Naito A; Hashimoto K; Toshiyama R; Fukuda S; Matsumoto S; Tokuoka M; Ide Y; Matsuyama J; Yokoyama S; Morimoto T; Fukushima Y; Nomura T; Kodama K; Yoshida S; Takeda M; Shiba I; Sasaki Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1982-4. PubMed ID: 23267950
[TBL] [Abstract][Full Text] [Related]
47. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
[TBL] [Abstract][Full Text] [Related]
48. Focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation.
Lee YH; Kim SH; Cho MY; Shim KY; Kim MS
AJR Am J Roentgenol; 2007 May; 188(5):W459-63. PubMed ID: 17449744
[TBL] [Abstract][Full Text] [Related]
49. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.
Roncalli M; Sciarra A; Tommaso LD
Clin Mol Hepatol; 2016 Jun; 22(2):199-211. PubMed ID: 27189732
[TBL] [Abstract][Full Text] [Related]
50. [Highly differentiated hepatocellular tumors. Concepts, criteria, and differential diagnosis].
Schrimacher P; Prange W; Dries V; Dienes HP
Pathologe; 2001 Nov; 22(6):407-16. PubMed ID: 11766640
[TBL] [Abstract][Full Text] [Related]
51. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
[TBL] [Abstract][Full Text] [Related]
52. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
[TBL] [Abstract][Full Text] [Related]
53. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
[TBL] [Abstract][Full Text] [Related]
54. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
[TBL] [Abstract][Full Text] [Related]
55. [Focal nodular hyperplasia of liver: a clinicopathologic study of 238 patients].
Chen LL; Ji Y; Xu JF; Lu SH; Hou YY; Hou J; Sujie A; Zeng HY; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):17-22. PubMed ID: 21429353
[TBL] [Abstract][Full Text] [Related]
56. [Focal nodular hyperplasia].
Bjerring PN; Jacobsen O; Biagini M; Skjoldbye B; Horn T
Ugeskr Laeger; 2007 Jan; 169(5):410-4. PubMed ID: 17280634
[TBL] [Abstract][Full Text] [Related]
57. Intratumoral sampling variability in hepatocellular carcinoma: a case report.
Senes G; Fanni D; Cois A; Uccheddu A; Faa G
World J Gastroenterol; 2007 Aug; 13(29):4019-21. PubMed ID: 17663522
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples.
Siddiqui MT; Saboorian MH; Gokaslan ST; Ashfaq R
Cancer; 2002 Feb; 96(1):49-52. PubMed ID: 11836703
[TBL] [Abstract][Full Text] [Related]
59. Utilization of spectrins βI and βIII in diagnosis of hepatocellular carcinoma.
Hu S; Jue D; Albanese J; Wang Y; Liu Q
Ann Diagn Pathol; 2019 Apr; 39():86-91. PubMed ID: 30798076
[TBL] [Abstract][Full Text] [Related]
60. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment.
Herman P; Pugliese V; Machado MA; Montagnini AL; Salem MZ; Bacchella T; D'Albuquerque LA; Saad WA; Machado MC; Pinotti HW
World J Surg; 2000 Mar; 24(3):372-6. PubMed ID: 10658075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
